BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37997502)

  • 21. The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.
    Ding C; Shi T; Wu G; Man J; Han H; Cui Y
    Bioengineered; 2022 Mar; 13(3):6629-6640. PubMed ID: 35213273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-760 mediated the proliferation and metastasis of hepatocellular carcinoma cells by regulating HMGA2.
    Wang Q; Wang G; Xu X; Chen Z
    Pathol Res Pract; 2021 Jun; 222():153420. PubMed ID: 33887625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA‑15b‑5p exerts its tumor repressive role via targeting GDI2: A novel insight into the pathogenesis of thyroid carcinoma.
    Zou J; Qian J; Fu H; Yin F; Zhao W; Xu L
    Mol Med Rep; 2020 Oct; 22(4):2723-2732. PubMed ID: 32945458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
    Ma S; Fu T; Zhao S; Gao M
    Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.
    Han S; Han B; Li Z; Sun D
    Cell Cycle; 2019 Oct; 18(19):2524-2537. PubMed ID: 31416393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
    Dong H; Cao W; Xue J
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem cells-originated exosomal microRNA-152 impairs proliferation, invasion and migration of thyroid carcinoma cells by interacting with DPP4.
    Tang M; Wang Q; Wang K; Wang F
    J Endocrinol Invest; 2020 Dec; 43(12):1787-1796. PubMed ID: 32876927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of novel long intergenic non‑coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.
    Tan J; Liu L; Zuo Z; Song B; Cai T; Ding D; Lu Y; Ye X
    Oncol Rep; 2020 Oct; 44(4):1489-1501. PubMed ID: 32945494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kruppel-like factor 13 acts as a tumor suppressor in thyroid carcinoma by downregulating IFIT1.
    Liu Y; Song Y; He Y; Kong Z; Li H; Zhu Y; Liu S
    Biol Direct; 2023 Oct; 18(1):65. PubMed ID: 37817224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p/CREB1 axis.
    Wang J; Liu Y; Cai H; Jiang H; Li W; Shi Y
    Bioengineered; 2021 Dec; 12(1):6264-6274. PubMed ID: 34499007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LINC00473 promotes hepatocellular carcinoma progression via acting as a ceRNA for microRNA-195 and increasing HMGA2 expression.
    Mo J; Li B; Zhou Y; Xu Y; Jiang H; Cheng X; Wu X; Zhang Y
    Biomed Pharmacother; 2019 Dec; 120():109403. PubMed ID: 31562977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
    Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
    J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of CREB1 inhibits tumor growth of human gastric cancer in vitro and in vivo.
    Rao M; Zhu Y; Cong X; Li Q
    Oncol Rep; 2017 Jun; 37(6):3361-3368. PubMed ID: 28498439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA ATP1A1-AS1 inhibits cell proliferation and promotes cell apoptosis in thyroid carcinoma by regulating the miR-620/IRF2BP2 axis.
    Jia J; Liu Y; Yang X; Wu Z; Xu X; Kang F; Liu Y
    Am J Med Sci; 2023 Jan; 365(1):73-83. PubMed ID: 36002076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-130a-3p impedes the progression of papillary thyroid carcinoma through downregulation of KPNB1 by targeting PSME3.
    Wang Y; Xu J; Zhu X; Kuang H
    Endocrine; 2023 Oct; 82(1):96-107. PubMed ID: 37166548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CircFAM73A promotes the cancer stem cell-like properties of gastric cancer through the miR-490-3p/HMGA2 positive feedback loop and HNRNPK-mediated β-catenin stabilization.
    Xia Y; Lv J; Jiang T; Li B; Li Y; He Z; Xuan Z; Sun G; Wang S; Li Z; Wang W; Wang L; Xu Z
    J Exp Clin Cancer Res; 2021 Mar; 40(1):103. PubMed ID: 33731207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p.
    Zhong J; He C; Xu F; Xu X; Liu L; Xu M; Guo Z; Wang Y; Liao J; Li Y
    J Orthop Surg Res; 2020 Sep; 15(1):374. PubMed ID: 32883329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulated ANP32E promotes the thyroid carcinoma cell proliferation and migration via activating AKT/mTOR/HK2-mediated glycolysis.
    Huang J; Gao W; Liu H; Yin G; Duan H; Huang Z; Zhang Y
    Gene; 2020 Aug; 750():144681. PubMed ID: 32304784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
    Cai J; Shen G; Liu S; Meng Q
    Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma.
    Zhang H; Tang Z; Deng C; He Y; Wu F; Liu O; Hu C
    Oral Dis; 2017 Mar; 23(2):255-264. PubMed ID: 27809392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.